Cantor Fitzgerald Weighs in on Merck & Co., Inc.'s FY2024 Earnings (NYSE:MRK)

Merck & Co., Inc. (NYSE:MRK – Free Report) – Equities researchers at Cantor Fitzgerald lifted their FY2024 EPS estimates for Merck & Co., Inc. in a research report issued to clients and investors on Friday, April 26th. Cantor Fitzgerald analyst L. Chen now expects that the company will earn $8.53 per share for the year, […]

Related Keywords

Colorado ,United States ,Wellington ,New Zealand General ,New Zealand ,Joseph Romanelli ,Steven Mizell ,Societe Generale ,Gardasil ,Merck Co Inc ,Institutional Trading Of Merck Co Inc ,Public Employees Retirement Association Of Colorado ,Animal Health ,Charles Schwab Investment Management Inc ,Wellington Management Group ,News Ratings For Merck Co ,Cantor Fitzgerald ,Securities Exchange Commission ,Berenberg Bank ,Wells Fargo Company ,Norges Bank ,Merck Co ,Free Report ,Get Free Report ,Management Group ,Schwab Investment Management ,Nova Scotia ,Public Employees Retirement Association ,Employees Retirement Association ,Exchange Commission ,Live Oral ,Nyse Mrk ,Mrk ,Medical ,58933y10 ,Earnings Estimates ,